Enteroids to Study Pediatric Intestinal Drug Transport
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Eva J Streekstra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Toxicology, Department of Pharmacy, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. Hauptthemen laut MEDLINE: Intestinal Mucosa, ATP Binding Cassette Transporter, Subfamily G, Member 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radboud Universitair Medisch Centrum.
Abstract (Originalsprache)
Intestinal maturational changes after birth affect the pharmacokinetics (PK) of drugs, having major implications for drug safety and efficacy. However, little is known about ontogeny-related PK patterns in the intestine. To explore the accuracy of human enteroid monolayers for studying drug transport in the pediatric intestine, we compared the drug transporter functionality and expression in enteroid monolayers and tissue from pediatrics and adults. Enteroid monolayers were cultured of 14 pediatric [median (range) age: 44 weeks (2 days-13 years)] and 5 adult donors, in which bidirectional drug transport experiments were performed. In parallel, we performed similar experiments with tissue explants in Ussing chamber using 11 pediatric [median (range) age: 54 weeks (15 weeks-10 years)] and 6 adult tissues. Enalaprilat, propranolol, talinolol, and rosuvastatin were used to test paracellular, transcellular, and transporter-mediated efflux by P-gp and breast cancer resistance protein (BCRP), respectively. In addition, we compared the expression patterns of ADME-related genes in pediatric and adult enteroid monolayers with tissues using RNA sequencing. Efflux transport by P-gp and BCRP was comparable between the enteroids and tissue. Efflux ratios (ERs) of talinolol and rosuvastatin by P-gp and BCRP, respectively, were higher in enteroid monolayers compared to Ussing chamber, likely caused by experimental differences in model setup and cellular layers present. Explorative statistics on the correlation with age showed trends of increasing ER with age for P-gp in enteroid monolayers; however, it was not significant. In the Ussing chamber setup, lower enalaprilat and propranolol transport was observed with age. Importantly, the RNA sequencing pathway analysis revealed that age-related variation in drug metabolism between neonates and adults was present in both enteroids and intestinal tissue. Age-related differences between 0 and 6 months old and adults were observed in tissue as well as in enteroid monolayers, although to a lesser extent. This study provides the first data for the further development of pediatric enteroids as an in vitro model to study age-related variation in drug transport. Overall, drug transport in enteroids was in line with data obtained from ex vivo tissue (using chamber) experiments. Additionally, pathway analysis showed similar PK-related differences between neonates and adults in both tissue and enteroid monolayers. Given the challenge to elucidate the effect of developmental changes in the pediatric age range in human tissue, intestinal enteroids derived from pediatric patients could provide a versatile experimental platform to study pediatric phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology and Toxicology, Department of Pharmacy, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
- Department of Metabolic Health Research, Netherlands Organization for Applied Scientific Research (TNO), Leiden 2333BE, The Netherlands.
- Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3584 CS, The Netherlands.
- Department of Surgery, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
- Department of Pediatrics, Division of Neonatology, Radboud University Medical Center, Amalia Children's Hospital, Nijmegen 6525GA, The Netherlands.
- Department of Surgery, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
ORCID-Profile: Sander Bervoets, Saskia N de Wildt
Förderung
- Radboud Universitair Medisch Centrum
Zitieren
APA
Streekstra, E. J., Keuper-Navis, M., van den Heuvel, J. J. M. W., van den Broek, P., Stommel, M. W. J., de Boode, W., Botden, S., Bervoets, S., O'Gorman, L., Greupink, R., Russel, F. G. M., van de Steeg, E., & de Wildt, S. N. (2024). Enteroids to Study Pediatric Intestinal Drug Transport. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00339
Vancouver
Streekstra EJ, Keuper-Navis M, van den Heuvel JJMW, van den Broek P, Stommel MWJ, de Boode W, et al. Enteroids to Study Pediatric Intestinal Drug Transport. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00339
BibTeX
@article{Streekstra2024,
author = {Streekstra, Eva J and Keuper-Navis, Marit and van den Heuvel, Jeroen J M W and van den Broek, Petra and Stommel, Martijn W J and de Boode, Willem and Botden, Sanne and Bervoets, Sander and O'Gorman, Luke and Greupink, Rick and Russel, Frans G M and van de Steeg, Evita and de Wildt, Saskia N},
title = {Enteroids to Study Pediatric Intestinal Drug Transport},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00339}
}
EUVIMED